Prevention is better than cure, or what we know about venous thromboembolism in patients with advanced cancer


Part I. Risk factors and epidemiology of venous thromboembolism in patients with advanced cancer

Serejko-Banaś K, Ciałkowska-Rysz A. Prevention is better than cure, or what we know about venous thromboembolism in patients with advanced cancer


Part I. Risk factors and epidemiology of venous thromboembolism in patients with advanced cancer. Medycyna Paliatywna/Palliative Medicine. 2022;14(4):183-188. doi:10.5114/pm.2022.127090.

APA

Serejko-Banaś, K.,  & Ciałkowska-Rysz, A. (2022). Prevention is better than cure, or what we know about venous thromboembolism in patients with advanced cancer


Part I. Risk factors and epidemiology of venous thromboembolism in patients with advanced cancer. Medycyna Paliatywna/Palliative Medicine, 14(4), 183-188. https://doi.org/10.5114/pm.2022.127090

Chicago

Serejko-Banaś, Katarzyna Ewa,  and Aleksandra Ciałkowska-Rysz. 2022. "Prevention is better than cure, or what we know about venous thromboembolism in patients with advanced cancer


Part I. Risk factors and epidemiology of venous thromboembolism in patients with advanced cancer". Medycyna Paliatywna/Palliative Medicine 14 (4): 183-188. doi:10.5114/pm.2022.127090.

Harvard

Serejko-Banaś, K.,  and Ciałkowska-Rysz, A. (2022). Prevention is better than cure, or what we know about venous thromboembolism in patients with advanced cancer


Part I. Risk factors and epidemiology of venous thromboembolism in patients with advanced cancer. Medycyna Paliatywna/Palliative Medicine, 14(4), pp.183-188. https://doi.org/10.5114/pm.2022.127090

MLA

Serejko-Banaś, Katarzyna Ewa et al. "Prevention is better than cure, or what we know about venous thromboembolism in patients with advanced cancer


Part I. Risk factors and epidemiology of venous thromboembolism in patients with advanced cancer." Medycyna Paliatywna/Palliative Medicine, vol. 14, no. 4, 2022, pp. 183-188. doi:10.5114/pm.2022.127090.

Vancouver

Serejko-Banaś K, Ciałkowska-Rysz A. Prevention is better than cure, or what we know about venous thromboembolism in patients with advanced cancer


Part I. Risk factors and epidemiology of venous thromboembolism in patients with advanced cancer. Medycyna Paliatywna/Palliative Medicine. 2022;14(4):183-188. doi:10.5114/pm.2022.127090.

PlumX metrics:

Venous thromboembolism occurring in the form of thrombosis or pulmonary embolism is an interdisciplinary problem of modern medicine. It is the third most common acute cardiovascular disease after myocardial infarction and stroke. Its incidence and risk of occurrence increase with age and the presence of multimorbidity and reduction in the patient’s functional capacity. Given the above, the patient receiving palliative care appears to be at particular risk of developing venous thromboembolism, and the physician caring for them should have clear guidelines for prevention. The first part of this paper presents an analysis of the available literature on assessing risk factors and the incidence of venous thromboembolism.

keywords:

Prevention is better than cure, or what we know about venous thromboembolism in patients with advanced cancer Part I. Risk factors and epidemiology of venous thromboembolism in patients with advanced cancer

Katarzyna Ewa Serejko-Banaś 1, 2 , Aleksandra Ciałkowska-Rysz 1, 2

venous thromboembolism, primary prophylaxis, palliative care

Katarzyna Ewa Serejko-Banaś

^{1, 2}

,

Aleksandra Ciałkowska-Rysz

^{1, 2}